triazoles has been researched along with Behavior Disorders in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (20.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagamine, T; Nakamura, M | 1 |
Iwata, N; Kishi, T; Kubo, M; Matsui, Y; Matsunaga, S; Ninomiya, K; Nomura, I; Okuya, M; Okuyama, Y; Oya, K; Sakuma, K | 1 |
Kharatmal, SB; Sharma, SS; Singh, JN | 1 |
Baumann, P; Engel, R; Fähndrich, E; Greil, W; Hippius, H; Horvath, A; Mayland, G; Rüther, E; Schmidt, LG; Zullino, D | 1 |
Borioni, A; Calamandrei, G; Domenici, MR; Lastoria, G; Martire, A; Popoli, P; Potenza, RL; Scattoni, ML; Venerosi, A | 1 |
ROE, A | 1 |
Yonkers, KA | 1 |
Chentsova-Dutton, YE; Ellenor, GL; Gillin, JC; Kline, NA; Kodsi, AB; Smith-Vaniz, A; Zisook, S | 1 |
Coleman, E; Gratzer, T; Nesvacil, L; Raymond, NC | 1 |
Izquierdo, JA; Llorca, G; Montejo, AL; Rico-Villademoros, F | 1 |
Baker, SM; Trivedi, MH | 1 |
Brady, KT; Charney, DS; Grothe, DR; Kaltsounis-Puckett, J; Laird, LK; Rush, AJ; Smith, SL; Wright, CW | 1 |
Amin, M; Ban, TA; Galvan, L; Lehmann, HE; Nair, NP | 1 |
Vinar, O | 1 |
3 review(s) available for triazoles and Behavior Disorders
Article | Year |
---|---|
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles | 1997 |
Clinical significance of monitoring early symptom change to predict outcome.
Topics: Algorithms; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Piperazines; Probability; Prognosis; Recurrence; Remission Induction; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Triazoles | 2001 |
Overview of psychiatric disorders and the role of newer antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Mental Disorders; Piperazines; Sleep Wake Disorders; Triazoles | 2002 |
4 trial(s) available for triazoles and Behavior Disorders
Article | Year |
---|---|
Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.
Topics: Adult; Aged; Azepines; Female; Humans; Male; Mental Disorders; Middle Aged; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Triazoles | 2019 |
Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Chronic Disease; Circadian Rhythm; Combat Disorders; Comorbidity; Drug Administration Schedule; Drug Resistance; Humans; Male; Mental Disorders; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Behavior; Sleep; Social Adjustment; Stress Disorders, Post-Traumatic; Triazoles; Veterans | 2000 |
Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Mental Disorders; Middle Aged; Minnesota; Obsessive-Compulsive Disorder; Paraphilic Disorders; Piperazines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles | 2000 |
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Panic Disorder; Piperazines; Prospective Studies; Remission, Spontaneous; Severity of Illness Index; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Triazoles | 2001 |
8 other study(ies) available for triazoles and Behavior Disorders
Article | Year |
---|---|
Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia.
Topics: Adult; Azepines; Blood Glucose; Comorbidity; Humans; Mental Disorders; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Triazoles | 2017 |
Rufinamide Improves Functional and Behavioral Deficits via Blockade of Tetrodotoxin-Resistant Sodium Channels in Diabetic Neuropathy.
Topics: Animals; Biophysical Phenomena; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Ganglia, Spinal; Mental Disorders; Neural Conduction; Neurons; Patch-Clamp Techniques; Rats; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin; Triazoles | 2015 |
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Community Mental Health Centers; Drug Prescriptions; Drug Utilization; Female; Germany; Hospitals, Psychiatric; Humans; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Piperazines; Practice Patterns, Physicians'; Reboxetine; Rural Health Services; Selective Serotonin Reuptake Inhibitors; Sex Factors; Switzerland; Triazoles; Urban Health Services | 2005 |
Voriconazole: serious adverse effects and interactions.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Drug Interactions; France; Heart Diseases; Humans; Mental Disorders; Pyrimidines; Skin Diseases; Triazoles; Vision Disorders | 2007 |
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Brain; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Huntington Disease; Learning Disabilities; Maze Learning; Mental Disorders; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Organ Culture Techniques; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2007 |
Psychological examinations of eminent biologists.
Topics: Biology; Chlorobenzenes; Intelligence Tests; Mental Disorders; Physical Examination; Triazoles | 1949 |
Comprehensive clinical studies with trazodone.
Topics: Animals; Antidepressive Agents; Barbiturates; Cats; Chlorpromazine; Guinea Pigs; Humans; Mental Disorders; Mice; Piperazines; Psychopharmacology; Pyridines; Rabbits; Rats; Triazoles | 1973 |
Introductory remarks: new agents in psychiatry.
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Humans; Mental Disorders; Piperazines; Pyridines; Schizophrenia; Triazoles; United States; United States Food and Drug Administration | 1973 |